Showing 23,074 news articles about Confidentiality, consent & medical ethics

Filters Content type: Editors' picks Topic: Confidentiality, consent & medical ethics

People’s rights when taking an HIV test, receiving medical treatment or taking part in research studies.

Pharmaceutical industry

Europe: Pharma industry denies it lobbied for medicines to move to DG Enterprise

Editor's pick
EurActiv
1 October 2014
Hepatitis C transmission & prevention

Investigating an outbreak of hepatitis C virus among MSM without HIV

Editor's pick
CATIE
1 October 2014
TB diagnosis

UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition

Editor's pick
EATG
1 October 2014
Health monitoring in resource-limited settings

Landmark HIV diagnostic access program will save $150m and help achieve new global goals on HIV

Editor's pick
UNAIDs press release
29 September 2014
Global health initiatives

Hard choices in Russia as the final HIV grant proposal is submitted

Editor's pick
Aidspan
25 September 2014
New & experimental HIV treatments

Gilead’s investigational tenofovir alafenamide (TAF)-based single tablet HIV regimen meets 48-week primary objective in two Phase 3 studies

Editor's pick
Gilead press release
25 September 2014
Hepatitis C treatment

Hepatitis C: Sit in of European patients to request access to new medicines, on occasion of the informal meeting of European Health Ministers in Milan

Editor's pick
EATG
22 September 2014
New & experimental HIV treatments

PREZCOBIX™ now available for Canadians living with HIV

Editor's pick
Newswire.ca
18 September 2014
Pharmaceutical industry

Open Letter to President-elect Jean-Claude Juncker on move of medicinal products and health technologies to the portfolio of the Commissioner for internal market and industry

Editor's pick
EATG
17 September 2014
Undetectable viral load & treatment as prevention

ART quells genital HIV shedding throughout menstrual cycle

Editor's pick
International AIDS Society
17 September 2014
New & experimental hepatitis C treatment

AbbVie 3D hepatitis C regimen is well-tolerated in Phase 3 trials

Editor's pick
HIVandHepatitis.com
15 September 2014
New & experimental HIV treatments

Long acting HIV drugs to be developed

Editor's pick
University of Liverpool press release
15 September 2014
New & experimental HIV treatments

New medicines in development give hope to patients with HIV/AIDS

Editor's pick
Pharmaceutical Research and Manufacturers of America
11 September 2014
New & experimental HIV treatments

Drug-level study shows feasibility of long-acting integrase inhibitor cabotegravir

Editor's pick
HIVand hepatitis.com
10 September 2014
Access to healthcare

Gilead close to sending $84,000 drug to poor countries

Editor's pick
Bloomberg
9 September 2014
Neurological & cognitive problems

Why HIV patients develop dementia

Editor's pick
EATG
5 September 2014
Hepatitis & HIV

US: HIV medical organizations challenge insurer restrictions to HCV treatment

Editor's pick
EATG / AAHIVM / HIVMA
4 September 2014
New & experimental hepatitis C treatment

PegLambda discontinued by BMS

Editor's pick
EATG
18 August 2014
Access to healthcare

MSF: Untangling the web of antiretroviral price reductions, 17th Edition

Editor's pick
MSF
8 August 2014
Hepatitis C treatment

Call to EU Ministers of health and CEOs of Abbvie, BMS, Gilead, Janssen and Merck/MSD regarding universal access to curative hepatitis C treatment in the EU and beyond

Editor's pick
EATG
30 July 2014
Harm reduction

European HIV+ IDUs share needles and inject more than HIV- IDUs

Editor's pick
International AIDS Society
18 July 2014
Adherence

Switch from single-tablet regimen to 3 tablets works in Denmark

Editor's pick
International AIDS Society
10 July 2014
Hepatitis C treatment

US: Studies look at hepatitis C care cascade and healthcare utilization

Editor's pick
HIVandHepatitis.com
8 July 2014
Tuberculosis & HIV

Apathy in TB fight: The Economist Intelligence Unit

Editor's pick
Stop TB Partnership
4 July 2014